Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Impinj to Participate in Upcoming Investor Conferences
-
AppHarvest announces Q2 2022 results showing continued improvements in core operations, progress to quadruple farm network and securing nondilutive expansion capital
-
Avalara to Present at Upcoming Investor Conferences
-
AppHarvest announces Q2 2022 results showing continued improvements in core operations, progress to quadruple farm network and securing nondilutive expansion capital
-
Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022
-
BigCommerce to Present at Upcoming Investor Conferences
-
Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Bandwidth Announces Second Quarter 2022 Financial Results Exceeding Guidance
-
Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
AngioDynamics to Present at the Canaccord Genuity Growth Conference
-
ATEX Announces Upsize of Previously Announced Private Placement Financing to up to $10.8 Million
-
Celcuity to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
Blackline Safety to Present at the 42nd Annual Canaccord Growth Conference
-
ZoomInfo to Participate in Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
-
Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
-
Artivion to Participate in Upcoming Investor Conferences
-
Neoleukin Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Neoleukin Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference
-
Wolfspeed To Participate in Upcoming Investor Conferences
-
Whole Earth Brands, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
AgroFresh Solutions to Participate in the Canaccord Genuity 42nd Annual Growth Conference
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
-
CANACCORD GENUITY GROUP INC. ANNOUNCES ACQUISITION OF UK ADVISORY BUSINESS RESULTS INTERNATIONAL GROUP LLP
-
DocGo Announces Upcoming Participation at the Canaccord Genuity 42nd Annual Growth Conference
-
2seventy bio to Participate in Upcoming Investor Conferences
-
Form 8.3 - [CareTech Holdings plc - 02 08 2022] - (CGWL)
-
Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
-
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
-
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
WindRose Health Investors Makes Strategic Investment in BPD
-
BioXcel Therapeutics to Participate at the Canaccord Genuity 42nd Annual Growth Conference
-
U3O8 Corp. Closes Upsized Private Placement of C$2,500,000
-
Nuvalent to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Cara Therapeutics, Inc. (CARA) to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Mynaric Announces Participation in Upcoming Jefferies Industrials Conference and Canaccord Genuity 42nd Annual Growth Conference
-
Atreca to Present at Upcoming Investor Conferences
-
Atreca to Present at Upcoming Investor Conferences
-
Cvent to Participate in Upcoming Investor Events
-
EverQuote to Participate in Upcoming Investor Conferences
-
Vivid Seats to Participate in Canaccord Genuity’s 2022 Growth Conference
-
EverQuote to Participate in Upcoming Investor Conferences
-
Proactive news headlines including Uber, Stuhini Exploration, Valeo Pharma, Copper Fox Metals, Context Therapeutics, South Star Battery Metals and Context Therapeutics
-
AeroVironment, Inc. Announces Participation in Upcoming Investor Conferences

